Investigating Metabolic Syndrome Markers and Body Mass Index Changes in Patients with Acne Vulgaris Treated with Isotretinoin: A Prospective Study

August 2024 in “ Journal of Cosmetic Dermatology ”

Afsaneh Sadeghzadeh‐Bazargan, Alireza Jafarzadeh, Fatemeh Danandeh, Sepideh Salehi

The study investigates the effects of oral isotretinoin on metabolic syndrome markers and body mass index (BMI) in patients with acne vulgaris. It concludes that isotretinoin is an effective treatment for acne vulgaris when administered at the correct dosage, providing a safe option with low complications. The study highlights the importance of monitoring dosage to ensure safety and efficacy in managing acne.

View this study on onlinelibrary.wiley.com →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Investigating Metabolic Syndrome Markers and Body Mass Index Changes in Patients with Acne Vulgaris Treated with Isotretinoin: A Prospective Study

7 citations , August 2024 in “Journal of Cosmetic Dermatology”

research Efficacy of Topical Minoxidil and Oral Spironolactone Versus Minoxidil and Finasteride in Androgenic Alopecia

August 2023 in “Journal of Cosmetic Dermatology”

Both minoxidil-spironolactone and minoxidil-finasteride treatments work for hair loss, but minoxidil-spironolactone is slightly more effective, especially in women.

research Insulin Sensitivity, Androgens, and Isotretinoin Therapy in Women with Severe Acne

19 citations , November 2012 in “Journal of Dermatological Treatment”

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.